About 300 reports

Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

209 pages • By Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Natural Killer Cells. This...

2 227 2 450 1 893
Mar 2017

Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017

365 pages • By Delve Insight

DelveInsight’s, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that...

2 500 2 750 2 125
Mar 2017

US Market Report for Cellular Allografts 2017 - MedCore

462 pages • By iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions The cellular allograft market is segmented into usage...

2 723 2 995 2 314
Mar 2017

Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2021

123 pages • By MarketsandMarkets

The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell...

5 045 5 650 4 338
Feb 2017

Global Human Embryonic Stem Cell (hESC) Research - Biotechnology

107 pages • By Global Industry Analysts

This report analyzes the Global market for Human Embryonic Stem Cell (hESC) Research in US$ Million. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs....

3 818 4 200 3 245
Feb 2017

Europe Stem Cell Market Growth, Trends and Forecasts (2017 - 2022)

113 pages • By Mordor Intelligence LLP

The European stem cell market is one of the most rapidly growing markets. The market is currently valued at USD 4.2 billion and is expected to grow at a CAGR of 15.7% over a forecast period. EuropeStem Cells Market- Market Dynamics Stem cell research is one of the most exciting areas of science in the 21st century...

3 500 3 850 2 975
Feb 2017

Global 3D Cell culture Market - Growth, Trends and Forecast (2017 - 2022)

211 pages • By Mordor Intelligence LLP

The global 3D Cell culture market was valued at an estimated $XX million in 2013 and is poised to grow at a CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. The market is expected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period of 2016 to 2021. Cell culture is a process by which...

3 864 4 250 3 284
Feb 2017

Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

140 pages • By MarketsandMarkets

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021” The global Regenerative medicine market is expected to reach USD 38.70 billion...

5 045 5 650 4 338
Feb 2017

Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025

100 pages • By Grand View Research

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue...

4 500 4 950 3 825
Feb 2017

2017-2021 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

120 pages • By Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next...

3 182 3 500 2 705
Feb 2017

Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

717 pages • By Currentpartnering

Summary The Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into...

2 723 2 995 2 314
Feb 2017

Global T-Cell Immunotherapy Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

309 pages • By P&S Market Research

Pipeline Overview T-cell immunotherapy mainly consists of T-cell receptor (TCR), Tumor-infiltrating lymphocytes (TILs) and Chimeric antigen receptors (CAR) T-cell therapy. TCR is a complex integral membrane protein that activates T-cells in response to an antigen. Major histocompatibility complex (MHC) molecules activates TCR by the presence...

3 545 3 900 3 014
Jan 2017

Global Regenerative Medicine - Pharmaceuticals

303 pages • By Global Industry Analysts

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these...

4 500 4 950 3 825
Jan 2017

Global Single Cell Analysis Market Analysis & Trends - Industry Forecast to 2025

170 pages • By Accuray Research LLP

The Global Single Cell Analysis Market is poised to grow at a CAGR of around 18.9% over the next decade to reach approximately $6.92 billion by 2025. Some of the prominent trends that the market is witnessing include microfluidics integration in single cell analysis, Asia Pacific region provides huge growth potential, huge R&D in stem cell...

3 818 4 200 3 245
Jan 2017

Global Stem Cell Therapy Market 2017-2021

70 pages • By Infiniti Research Limited

About stem cell therapy Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells,...

3 398 3 500 2 922
Jan 2017

2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

120 pages • By Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next...

3 182 3 500 2 705
Jan 2017

Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

260 pages • By MarketsandMarkets

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virus filtration,...

5 045 5 650 4 338
Jan 2017

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development...

1 136 1 250 966
Jan 2017

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development...

1 136 1 250 966
Jan 2017

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast activation protein (FAP) antagonists. The DelveInsight’s Report covers the product profiles in various stages of development including...

1 136 1 250 966
Jan 2017

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Growth Hormone Deficiency Report is to understand...

1 818 2 000 1 545
Jan 2017

Growth Hormone (GH) Agonists -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Growth Hormone (GH) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone (GH) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I,...

1 136 1 250 966
Jan 2017

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency (GHD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics...

4 500 4 950 3 825
Jan 2017

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor 1 (FGF-1) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery,...

1 136 1 250 966
Jan 2017

Growth Hormone Antagonists -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 136 1 250 966
Jan 2017

Anti GM-CSF Antibody -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Anti GM-CSF Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 136 1 250 966
Jan 2017

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor (FGFR) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including...

1 136 1 250 966
Jan 2017

Interleukin (IL) Inhibitors -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 136 1 250 966
Jan 2017

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon Gamma Receptor (IFNGR) Binders. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 136 1 250 966
Jan 2017

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development...

1 136 1 250 966
Jan 2017